In This Guide:
- What ISHRS Is and Why Marketing Standards Exist
- Banned and Restricted Claims
- Trademark and Device Naming Rules
- How ISHRS Overlaps with FTC and Google Ads Policy
- What an ISHRS-Compliant Landing Page Looks Like
- What an ISHRS-Compliant Ad Looks Like
- Action Checklist for Member Practices
- FAQ
What ISHRS Is and Why Marketing Standards Exist
The International Society of Hair Restoration Surgery (ISHRS) is the largest professional medical organization dedicated to hair restoration. Membership signals to patients that a surgeon has met education and ethics standards beyond a basic medical license. That signal is worth money in a market flooded with med spas and non-surgeon operators running hair transplant clinics under supervising-physician arrangements.
ISHRS protects that signal by publishing patient education and ethics guidance that indirectly sets the bar for how member practices should market themselves. There is no single “ISHRS ad policy” document you can download and hand to a copywriter. Instead, the standards live across the Code of Ethics, patient advisory statements, and public statements the Society has made about deceptive advertising in the hair restoration space. If your marketing contradicts that guidance, you risk more than an ad account suspension. You risk your professional standing with the peer group that refers you cases and validates your credibility to prospective patients researching “is this doctor legit.”
This post paraphrases the spirit and substance of publicly available ISHRS patient advisories and ethics statements. We are not quoting internal clause numbers or member-only bylaws, because those are not ours to reproduce. What follows is a practical translation for the people who actually write the ads, landing pages, and scripts.
Banned and Restricted Claims
ISHRS has been consistent in public statements warning patients away from marketing language that overstates certainty or minimizes the reality of a surgical procedure. If you run marketing for a member practice, treat the following as a do-not-use list.
“Scarless” and “No Incision”
FUE reduces linear scarring compared to strip harvesting, but it does not eliminate scarring. Every extraction site is a wound. Describing FUE as scarless or incision-free misrepresents the procedure to a patient trying to make an informed decision.
- Banned: “Scarless hair restoration with zero incisions.”
- Compliant: “FUE minimizes visible linear scarring compared to strip harvesting. Individual extraction sites heal as small dot scars.”
Guaranteed Results
Graft survival, density, and growth timelines vary by patient, donor supply, technique, and post-op care. No reputable surgeon can guarantee a specific outcome.
- Banned: “Guaranteed 100% growth or your money back.”
- Compliant: “Results vary by patient. Your surgeon will review your donor density and candidacy during consultation.”
Hair “Multiplication” or “Cloning”
Hair multiplication and cloning are research concepts, not commercially available or FDA-approved procedures. No practice should market these as current offerings.
- Banned: “Now offering hair cloning to multiply your donor supply.”
- Compliant: “Ask your surgeon about current donor management techniques for your case. Hair multiplication technology is still in research and not yet clinically available.”
Absolute Downtime or Pain Claims
“Painless” and “no downtime” are absolute claims that vary patient to patient and invite both regulatory scrutiny and bad reviews.
- Banned: “Completely painless procedure with no downtime.”
- Compliant: “Most patients return to light activity within a few days. Your surgeon will walk you through the expected recovery timeline.”
Trademark and Device Naming Rules
Device names like NeoGraft, ARTAS, and SmartGraft are trademarks owned by their respective manufacturers. Using them in marketing carries two separate compliance obligations.
| Rule | Why It Matters |
|---|---|
| Only use a device trademark if your practice is an authorized user/owner of that system. | Manufacturers actively monitor unauthorized use and can pursue trademark claims against practices advertising a device they don’t own or lease. |
| Do not imply the device performs the procedure. The surgeon performs the procedure; the device assists. | ISHRS and the FTC both discourage marketing that shifts clinical credit from surgeon to machine, since it overstates automation and understates surgeon skill and judgment. |
| Do not use a competitor’s device name in your own ads or landing pages without authorization. | This is a straightforward trademark infringement risk that also confuses patients about which technology they’ll actually receive. |
| Disclose FDA clearance status accurately. | These are FDA-cleared devices for hair transplantation, not “FDA-approved cures” for hair loss. The distinction matters legally and ethically. |
If your practice owns a NeoGraft or ARTAS system, say so plainly: “Our practice performs FUE procedures using the ARTAS robotic system.” That’s a factual, compliant statement. What is not compliant is naming a device you don’t own, or naming any device in a way that suggests it guarantees an outcome the surgeon cannot guarantee.
How ISHRS Overlaps with FTC and Google Ads Policy
Practice owners often treat these as three separate compliance worlds. They are not. They converge on the same core principle: don’t say something you can’t substantiate, and don’t let the patient walk away with a false impression.
- FTC: Prohibits deceptive and unsubstantiated claims in advertising, including implied claims. A guarantee, a before/after photo without disclaimers, or a testimonial presented as typical when it isn’t, can all trigger FTC scrutiny.
- Google Ads healthcare policy: Restricts unproven medical claims, requires accurate representation of medical procedures, and can suspend advertiser accounts for repeated violations related to health claims, especially around cosmetic and surgical procedures.
- ISHRS: Adds a peer-professional layer on top of both. Even if an ad technically survives an FTC challenge or a Google Ads review, it can still violate the ethical marketing expectations ISHRS holds its members to, and that becomes a professional reputation issue among referring surgeons and at ISHRS-affiliated conferences.
The practical takeaway: if your copy would fail an ISHRS ethics review, it will almost certainly also fail an FTC substantiation test and a Google Ads healthcare policy review. Write to the strictest of the three and you clear all of them. For the Google-specific mechanics of this, see our Google Ads policy guide for hair restoration practices. For copy-level phrasing guardrails, see our safe FUE language guide.
What an ISHRS-Compliant Landing Page Looks Like
A compliant hair restoration landing page has a consistent shape. It leads with the surgeon’s credentials, describes the procedure accurately, avoids absolute language, and gives the patient a clear next step without pressure tactics.
- Headline: Names the procedure and the practice, not a promised outcome. Example: “FUE Hair Restoration in Austin, Led by Dr. [Name]” rather than “Get Your Hair Back Guaranteed.”
- Procedure description: States what FUE is, how grafts are harvested and placed, and that results vary by donor supply and individual healing.
- Device disclosure: If a named device is used, states the trademark correctly and clarifies the surgeon performs the procedure with the device’s assistance.
- Before/after photos: Include representative disclaimers (“individual results vary”) and avoid cherry-picked outlier results presented without context.
- Testimonials: Real patient testimonials, not written or implied by staff, with disclaimers that experiences vary.
- Call to action: Invites a consultation to determine candidacy rather than promising a specific result upon booking.
What an ISHRS-Compliant Ad Looks Like
Paid ads have less room than a landing page, which makes absolute language more tempting and more risky. Compare these side by side.
| Banned Ad Copy | Compliant Rewrite |
|---|---|
| “Scarless FUE, guaranteed results, no downtime.” | “FUE hair restoration with minimal linear scarring. Schedule a consultation to discuss your candidacy.” |
| “NeoGraft hair cloning now available.” | “NeoGraft-assisted FUE performed by board-certified surgeons. Ask about your donor area assessment.” |
| “100% natural results every time.” | “Natural-looking results are the goal of every procedure. Outcomes vary by patient and donor supply.” |
Notice the pattern: the compliant version still sells. It names the procedure, names the credential, and invites action. It just doesn’t promise an outcome the surgeon can’t control.
Action Checklist for Member Practices
- Audit all landing pages and ad copy for “scarless,” “guaranteed,” “painless,” “no downtime,” “cloning,” and “multiplication.”
- Confirm device trademarks (NeoGraft, ARTAS, SmartGraft) are used only if your practice is an authorized owner or licensee.
- Add “individual results vary” disclaimers to every before/after photo set.
- Review testimonials for implied-typical-result language and add disclaimers where needed.
- Cross-check ad copy against your Google Ads healthcare policy status before launching campaigns.
- Have a non-marketing staff member (ideally clinical) review copy for accuracy before publishing.
- Revisit this checklist quarterly, since ISHRS advisories and Google Ads healthcare policy both get updated periodically.
FAQ
Is ISHRS membership required to market a hair restoration practice legally?
No. ISHRS membership is voluntary and reflects professional education standards, not a legal marketing requirement. However, member practices are expected to hold their marketing to the Society’s ethics guidance, and non-compliance can affect standing within the organization.
Can I use the word “FUE” without mentioning scarring at all?
You can describe the procedure without dwelling on scarring, but if you make any claim about scar visibility (like “minimal scarring” or “less noticeable than strip”), that claim needs to be accurate and not overstated to “scarless.”
What happens if my ad account gets flagged for a banned claim?
Google Ads may pause the ad, require an appeal, or suspend the account for repeated violations. Beyond the ad account, an FTC complaint or an ISHRS ethics inquiry can follow if the claim is egregious or repeated across multiple channels.
Do these standards apply to non-surgeon staff who run our social media?
Yes. Any content published under the practice’s name, including social media managed by non-clinical staff, should follow the same compliance standards as paid ads and landing pages.
Key Takeaways
- ISHRS does not publish a single marketing rulebook, but its ethics guidance and public patient advisories set a clear standard: no guarantees, no absolute claims, accurate procedure descriptions.
- “Scarless,” “guaranteed,” “painless,” “no downtime,” “cloning,” and “multiplication” are all red-flag terms that need to be removed or rewritten.
- Device trademarks (NeoGraft, ARTAS, SmartGraft) can only be used by authorized owners/licensees, and should never imply the device replaces surgeon skill.
- ISHRS, FTC, and Google Ads healthcare policy overlap heavily. Writing to the strictest standard clears all three.
- A compliant landing page and ad still sell hard. They just sell the procedure and the surgeon’s expertise instead of a promised outcome.
This guide is part of VMMG’s ongoing hair restoration compliance series, including our upcoming comprehensive hair transplant marketing compliance guide.
